NextPlat FY2024 revenue $65.5M (+73% YoY); net loss widens to $14.0M

NextPlat Corp

Revenue $65.5M in FY2024 (+73% YoY) driven by full-year Healthcare Operations; net loss $14.0M ($0.68/diluted share) vs $3.8M loss ($0.22) in FY2023.
Gross margin fell to 24.8% due to medication price pressures and rising hardware costs; operating expenses $40.0M.
Completed all-stock merger with Progressive Care and acquisition of Outfitter Satellite; Healthcare filled 514k prescriptions.
China e-Commerce launched on Alibaba Tmall and JD.com; OPKO program extended to Japan; Florida Sunshine brand expected late Q2 2025.
Cash at year-end $20.0M; net cash burn $6.3M including $3.4M non-recurring merger costs and $1.0M Outfitter acquisition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.